AbbVie Bet To Swap Parkinson's Patent Claims Fails At PTAB
The Patent Trial and Appeal Board has canceled every claim in an AbbVie Inc. patent for a method of treating Parkinson's disease, but then rejected all the substitute claims proposed by...To view the full article, register now.
Already a subscriber? Click here to view full article